
Keywords: Chemotherapy; Drug resistance; Natural products; Sesquiterpenoids; Toxicology; ACE; angiotensin I-converting enzyme; ACT; artemisinin-based combination therapy; Akt; AKT serine/threonine kinase, v-akt murine thymoma viral oncogene homologue; AMP; adenosin